FBInvestor
Stocks / Fulcrum Therapeutics Inc
Institutional Ownership

Fulcrum Therapeutics Inc

CUSIP 359616109COMFULCQ1 2026

13D / 13G Filings
63
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
25.5%
Max % of class reported
Institutional Holders
163
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

63 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Ra Capital Management, L.P.13G/A9.9%6.65MSEC
2Dec 10, 2025Ra Capital Management, L.P.13G/A11.2%6.05MSEC
3Nov 13, 2025Adage Capital Management, L.P.13G/A4.5%2.43MSEC
4Oct 17, 2025Blackrock, Inc.13G/A6.0%3.27MSEC
5Aug 12, 2025Adage Capital Management, L.P.13G/A8.5%4.59MSEC
6May 2, 2025Suvretta Capital Management, LLC13G/A9.4%5.07MSEC
7Apr 17, 2025Blackrock, Inc.13G/A7.5%4.03MSEC
8Feb 12, 2025Adage Capital Management, L.P.13G5.6%3.00MSEC
9Jan 6, 2025Suvretta Capital Management, LLC13G6.3%3.40MSEC
10Dec 6, 2024Blackrock, Inc.13G10.3%5.58MSEC

53 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Fulcrum Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →